CVRx, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
CVRx, Inc. (CVRX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.22 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-06
- CVRx, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 162.34K shares, a 4.46% decline year-over-year.
- CVRx, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 1.06M shares, a 39.44% increase year-over-year.
- CVRx, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 29.90K shares, a 55.74% decline year-over-year.
- CVRx, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 94.15K shares, a 78.48% decline year-over-year.
- CVRx, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 1.05M shares, a 67.55% decline from fiscal 2024.
- CVRx, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 3.24M shares, a 178.65% increase from fiscal 2023.
- CVRx, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 1.16M shares, a 21.85% decline from fiscal 2022.
- CVRx, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 1.49M shares, a 5.32% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 162.34K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 1.22M shares 10-Q · filed 2026-08-06 | 1.25M shares derived: sum of 3 quarters · filed 2026-08-06 | 1.34M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 1.06M shares 10-Q · filed 2026-05-12 | 1.08M shares derived: sum of 2 quarters · filed 2026-05-12 | 1.18M shares derived: sum of 3 quarters · filed 2026-05-12 | 1.35M shares derived: sum of 4 quarters · filed 2026-05-12 |
| 2025-12-31 | 29.90K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | 124.05K shares derived: sum of 2 quarters · filed 2026-02-13 | 293.97K shares derived: sum of 3 quarters · filed 2026-02-13 | 1.05M shares 10-K · filed 2026-02-13 |
| 2025-09-30 | 94.15K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 264.07K shares derived: sum of 2 quarters · filed 2025-11-06 | 1.02M shares 10-Q · filed 2025-11-06 | 1.09M shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-06-30 | 169.92K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | 926.57K shares 10-Q · filed 2025-08-05 | 994.13K shares derived: sum of 3 quarters · filed 2026-02-13 | 1.43M shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-03-31 | 756.65K shares 10-Q · filed 2025-05-09 | 824.21K shares derived: sum of 2 quarters · filed 2026-02-13 | 1.26M shares derived: sum of 3 quarters · filed 2026-02-13 | 1.98M shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-12-31 | 67.56K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | 505.09K shares derived: sum of 2 quarters · filed 2026-02-13 | 1.22M shares derived: sum of 3 quarters · filed 2026-02-13 | 3.24M shares 10-K · filed 2026-02-13 |
| 2024-09-30 | 437.53K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | 1.16M shares derived: sum of 2 quarters · filed 2024-11-01 | 3.17M shares 10-Q · filed 2024-11-01 | 3.25M shares derived: sum of 4 quarters · filed 2025-02-18 |
| 2024-06-30 | 718.18K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | 2.73M shares 10-Q · filed 2024-08-02 | 2.81M shares derived: sum of 3 quarters · filed 2025-02-18 | 2.90M shares derived: sum of 4 quarters · filed 2025-02-18 |
| 2024-03-31 | 2.01M shares 10-Q · filed 2024-05-10 | 2.09M shares derived: sum of 2 quarters · filed 2025-02-18 | 2.18M shares derived: sum of 3 quarters · filed 2025-02-18 | 2.33M shares derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-12-31 | 75.05K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | 168.53K shares derived: sum of 2 quarters · filed 2025-02-18 | 314.45K shares derived: sum of 3 quarters · filed 2025-02-18 | 1.16M shares 10-K · filed 2025-02-18 |
| 2023-09-30 | 93.47K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | 239.40K shares derived: sum of 2 quarters · filed 2023-10-31 | 1.09M shares 10-Q · filed 2023-10-31 | 1.17M shares derived: sum of 4 quarters · filed 2023-10-31 |
| 2023-06-30 | 145.92K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | 993.40K shares 10-Q · filed 2023-08-03 | 1.07M shares derived: sum of 3 quarters · filed 2023-08-03 | 1.42M shares derived: sum of 4 quarters · filed 2023-08-03 |
| 2023-03-31 | 847.48K shares 10-Q · filed 2023-05-11 | 927.50K shares derived: sum of 2 quarters · filed 2023-05-11 | 1.27M shares derived: sum of 3 quarters · filed 2023-05-11 | 1.70M shares derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | 80.02K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | 424.49K shares derived: sum of 2 quarters · filed 2023-02-10 | 853.82K shares derived: sum of 3 quarters · filed 2023-02-10 | 1.49M shares 10-K · filed 2023-02-10 |
| 2022-09-30 | 344.46K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | 773.79K shares derived: sum of 2 quarters · filed 2022-11-04 | 1.41M shares 10-Q · filed 2022-11-04 | 1.58M shares derived: sum of 4 quarters · filed 2023-02-10 |
| 2022-06-30 | 429.33K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | 1.06M shares 10-Q · filed 2022-08-01 | 1.24M shares derived: sum of 3 quarters · filed 2023-02-10 | 1.27M shares derived: sum of 4 quarters · filed 2023-02-10 |
| 2022-03-31 | 632.99K shares 10-Q · filed 2022-05-02 | 806.28K shares derived: sum of 2 quarters · filed 2023-02-10 | 839.47K shares derived: sum of 3 quarters · filed 2023-02-10 | |
| 2021-12-31 | 173.29K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | 206.48K shares derived: sum of 2 quarters · filed 2023-02-10 | 1.41M shares 10-K · filed 2023-02-10 | |
| 2021-09-30 | 33.19K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | 1.24M shares 10-Q · filed 2021-11-08 | ||
| 2021-06-30 | 1.21M shares 10-Q · filed 2021-08-09 | |||
| 2020-12-31 | 517.57K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | 517.57K shares 10-K · filed 2022-02-22 | ||
| 2020-09-30 | 0.00 shares 10-Q · filed 2021-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |